WallStSmart

DR Horton Inc (DHI)vsHovnanian Enterprises Inc (HOV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DR Horton Inc generates 1043% more annual revenue ($33.35B vs $2.92B). DHI leads profitability with a 9.5% profit margin vs 1.3%. DHI appears more attractively valued with a PEG of 1.28. DHI earns a higher WallStSmart Score of 55/100 (C).

DHI

Buy

55

out of 100

Grade: C

Growth: 2.7Profit: 6.0Value: 5.3Quality: 8.5
Piotroski: 3/9Altman Z: 5.10

HOV

Hold

45

out of 100

Grade: D

Growth: 2.7Profit: 4.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHISignificantly Overvalued (-52.8%)

Margin of Safety

-52.8%

Fair Value

$100.86

Current Price

$146.49

$45.63 premium

UndervaluedFair: $100.86Overvalued

Intrinsic value data unavailable for HOV.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHI4 strengths · Avg: 8.8/10
Altman Z-ScoreHealth
5.1010/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

P/E RatioValuation
14.5x8/10

Attractively priced relative to earnings

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

HOV1 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Areas to Watch

DHI4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-2.3%2/10

Revenue declined 2.3%

EPS GrowthGrowth
-13.2%2/10

Earnings declined 13.2%

Free Cash FlowQuality
$-449.70M2/10

Negative free cash flow — burning cash

HOV4 concerns · Avg: 3.8/10
PEG RatioValuation
2.004/10

Expensive relative to growth rate

P/E RatioValuation
31.8x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.924/10

Grey zone — moderate risk

Market CapQuality
$672.08M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : DHI

The strongest argument for DHI centers on Altman Z-Score, Debt/Equity, P/E Ratio. PEG of 1.28 suggests the stock is reasonably priced for its growth.

Bull Case : HOV

The strongest argument for HOV centers on Price/Book.

Bear Case : DHI

The primary concerns for DHI are Piotroski F-Score, Revenue Growth, EPS Growth.

Bear Case : HOV

The primary concerns for HOV are PEG Ratio, P/E Ratio, Altman Z-Score. Thin 1.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

HOV carries more volatility with a beta of 1.87 — expect wider price swings.

DHI is growing revenue faster at -2.3% — sustainability is the question.

HOV generates stronger free cash flow (-70M), providing more financial flexibility.

Monitor RESIDENTIAL CONSTRUCTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DHI scores higher overall (55/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DR Horton Inc

CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION · USA

D.R. Horton, Inc. is a home construction company incorporated in Delaware and headquartered in Arlington, Texas.

Hovnanian Enterprises Inc

CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION · USA

Hovnanian Enterprises, Inc. is dedicated to the design, construction, marketing and sales of residential homes in the United States. The company is headquartered in Matawan, New Jersey.

Want to dig deeper into these stocks?